Aurinia Pharmaceuticals
AUPH
#4598
Rank
HK$16.19 B
Marketcap
HK$122.85
Share price
1.09%
Change (1 day)
72.95%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): HK$0.65 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.26 Billion. In 2024 the company made an earning of HK$95.55 Million, an increase over its 2023 earnings that were of -HK$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.65 B586.19%
2024 HK$95.55 M-116.44%
2023 -HK$0.59 Billion-31.8%
2022 -HK$0.86 Billion-39.4%
2021 -HK$1.41 Billion61.9%
2020 -HK$0.87 Billion-9.73%
2019 -HK$0.97 Billion92.65%
2018 -HK$0.5 Billion36.39%
2017 -HK$0.37 Billion106.29%
2016 -HK$0.18 Billion-15.4%
2015 -HK$0.21 Billion65.84%
2014 -HK$0.13 Billion129.82%
2013 -HK$55.05 Million-26.6%
2012 -HK$75 Million
2010 -HK$42.46 Million-39.22%
2009 -HK$69.86 Million-43.78%
2008 -HK$0.13 Billion-53.19%
2007 -HK$0.27 Billion42.97%
2006 -HK$0.19 Billion-23.03%
2005 -HK$0.25 Billion36.1%
2004 -HK$0.18 Billion172.57%
2003 -HK$65.04 Million484.61%
2002 -HK$11.13 Million
2000 -HK$52.83 Million453.81%
1999 -HK$9.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$40.02 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$42.68 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-HK$0.18 Billion-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA